Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism

FEBS Letters

Volumn 460, Issue 2, 1999, Pages 321-327

  Oscarson, Mikael ^a   McLellan, Roman A ^a   Gullstén, Harriet ^b   Agúndez, José A G ^c   Benítez, Julio ^c   Rautio, Arja ^b   Raunio, Hannu ^b   Pelkonen, Olavi ^b   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cotinine; Coumarin; Cytochrome P450; Cytochrome P450 2A6; Lung cancer; Nicotine

Indexed keywords

COTININE; COUMARIN; CYTOCHROME P450 ISOENZYME; NICOTINE;

ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; EPIDEMIOLOGY; GENE CONVERSION; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MUTATION; NONHUMAN; PRIORITY JOURNAL; SMOKING;

APOPROTEINS; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; BLOTTING, SOUTHERN; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; HUMANS; MALE; MIXED FUNCTION OXYGENASES; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NICOTINE; PHENOTYPE; POLYMORPHISM, GENETIC; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY, NUCLEIC ACID; SMOKING; SPAIN; STEROID HYDROXYLASES; TRANSFECTION;

EID: 0032698297     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01364-2     Document Type: Article

References (40)

1. Ingelman-Sundberg M., Oscarson M., McLellan R.A. Trends Pharmacol. Sci. 20:1999;342-349.
2. Oscarson M., Gullstén H., Rautio A., Bernal M.L., Sinues B., Dahl M.-L., Stengård J.H., Pelkonen O., Raunio H., Ingelman-Sundberg M. FEBS Lett. 438:1998;201-205.
3. Benowitz N.L., Jacob P. NIDA Res. Monogr. 173:1997;48-64.
4. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. Drug Metab. Dispos. 24:1996;1212-1217.
5. Messina E.S., Tyndale R.F., Sellers E.M. J. Pharmacol. Exp. Ther. 282:1997;1608-1614.
6. Yamazaki H., Inoue K., Hashimoto M., Shimada T. Arch. Toxicol. 73:1999;65-70.
7. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. J. Pharmacol. Exp. Ther. 277:1996;1010-1015.
8. Kitagawa K., Kunugita N., Katoh T., Yang M., Kawamoto T. Biochem. Biophys. Res. Commun. 262:1999;146-151.
9. Iscan M., Rostami H., Iscan M., Guray T., Pelkonen O., Rautio A. Eur. J. Clin. Pharmacol. 47:1994;315-318.
10. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Pharmacogenetics. 2:1992;227-233.
11. Cholerton S., Idle M.E., Vas A., Gonzalez F.J., Idle J.R. J. Chromatogr. 575:1992;325-330.
12. Hadidi H., Irshaid Y., Vagbo C.B., Brunsvik A., Cholerton S., Zahlsen K., Idle J.R. Eur. J. Clin. Pharmacol. 54:1998;437-441.
13. Shimada T., Yamazaki H., Guengerich F.P. Xenobiotica. 26:1996;395-403.
14. Yun C.H., Shimada T., Guengerich F.P. Mol. Pharmacol. 40:1991;679-685.
15. Pearce R., Greenway D., Parkinson A. Arch. Biochem. Biophys. 298:1992;211-225.
16. Hadidi H., Zahlsen K., Idle J.R., Cholerton S. Food Chem. Toxicol. 35:1997;903-907.
17. Yamano S., Tatsuno J., Gonzalez F.J. Biochemistry. 29:1990;1322-1329.
18. Oscarson M., McLellan R.A., Gullstén H., Yue Q.-Y., Lang M.A., Bernal M.L., Sinues B., Hirvonen A., Raunio H., Pelkonen O., Ingelman-Sundberg M. FEBS Lett. 448:1999;105-110.
19. Nunoya K.I., Yokoi T., Kimura K., Kainuma T., Satoh K., Kinoshita M., Kamataki T. J. Pharmacol. Exp. Ther. 289:1999;437-442.
20. Fernandez-Salguero P., Hoffman S.M., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J.D., Evans W.E., Idle J.R., Gonzalez F.J. Am. J. Hum. Genet. 57:1995;651-660.
21. Pianezza M.L., Sellers E.M., Tyndale R.F. Nature. 393:1998;750.
22. Miyamoto M., Umetsu Y., Dosaka-Akita H., Sawamura Y., Yokota J., Kunitoh H., Nemoto N., Sato K., Ariyoshi N., Kamataki T. Biochem. Biophys. Res. Commun. 261:1999;658-660.
23. Gullstén H., Agúndez J.A., Benítez J., Laara E., Ladero J.M., Diaz-Rubio M., Fernandez-Salguero P., Gonzalez F., Rautio A., Pelkonen O., Raunio H. Pharmacogenetics. 7:1997;247-250.
24. Bernal Ruiz, M.L., Sinues, B., Johansson, I., McLellan, R.A., Dahl, M.-L., Ingelman-Sundberg, M. and Bertilsson, L. (1999) Pharmacogenetics (in press).
25. Johansson I., Yue Q.Y., Dahl M.L., Heim M., Säwe J., Bertilsson L., Meyer U.A., Sjöqvist F., Ingelman-Sundberg M. Eur. J. Clin. Pharmacol. 40:1991;553-556.
26. Hoffman S.M., Fernandez-Salguero P., Gonzalez F.J., Mohrenweiser H.W. J. Mol. Evol. 41:1995;894-900.
27. Salonpää P., Hakkola J., Pasanen M., Pelkonen O., Vähäkangas K., Battula N., Nouso K., Raunio H. Eur. J. Pharmacol. 248:1993;95-102.
28. Krynetski E.Y., Drutsa V.L., Kovaleva I.E., Luzikov V.N. Pharmacogenetics. 5:1995;103-109.
29. Urban P., Cullin C., Pompon D. Biochimie. 72:1990;463-472.
30. Truan G., Cullin C., Reisdorf P., Urban P., Pompon D. Gene. 125:1993;49-55.
31. Bellamine A., Gautier J.C., Urban P., Pompon D. Eur. J. Biochem. 225:1994;1005-1013.
32. Oscarson M., Hidestrand M., Johansson I., Ingelman-Sundberg M. Mol. Pharmacol. 52:1997;1034-1040.
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265-275.
34. Omura T., Sato R. J. Biol. Chem. 239:1964;2370-2378.
35. Aitio A. Anal. Biochem. 85:1978;488-491.
36. Wedell A. Acta Paediatr. 87:1998;159-164.
37. Daly A.K., Brockmöller J., Broly F., Eichelbaum M., Evans W.E., Gonzalez F.J., Huang J.D., Idle J.R., Ingelman-Sundberg M., Ishizaki T., Jacqz-Aigrain E., Meyer U.A., Nebert D.W., Steen V.M., Wolf C.R., Zanger U.M. Pharmacogenetics. 6:1996;193-201.
38. Gotoh O. J. Biol. Chem. 267:1992;83-90.
39. London S.J., Idle J.R., Daly A.K., Coetzee G.A. Lancet. 353:1999;898-899.
40. Chen G.F., Tang Y.M., Green B., Lin D.X., Guengerich F.P., Daly A.K., Caporaso N.E., Kadlubar F.F. Pharmacogenetics. 9:1999;327-332.